Fig. 2From: Blinatumomab therapy for B cell acute lymphoblastic leukemia accompanied by persistent or relapsed low-level MRD prior to hematopoietic stem cell transplantation in Chinese children: a case seriesFlowchart of the treatment protocol used in the three cases. PVDL, prednisolone, vincristine, daunorubicin and L-asparaginase; CAT, cyclophosphamide, cytarabine and mercaptopurine; HDMTX, high-dose methotrexate; DEAL, dexamethasone, cytarabine, etoposide and L-asparaginase; HSCT, hematopoietic stem cell transplantation; CAT + , cyclophosphamide, cytarabine, mercaptopurine, vincristine and L-asparaginase, with or without bortezomibBack to article page